ReviewExperimental and therapeutic medicine2025

Potential of CXCR1/2 as a target for the treatment of inflammation and cancer (Review).

Jing-Ming Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.